Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 168

Similar articles for PubMed (Select 23259781)

1.

Circulating microRNAs (cmiRNAs) as novel potential biomarkers for hepatocellular carcinoma.

Qi J, Wang J, Katayama H, Sen S, Liu SM.

Neoplasma. 2013;60(2):135-42.

2.

Circulating microRNAs (cmiRNAs) as novel potential biomarkers for hepatocellular carcinoma.

Qi J, Wang J, Katayama H, Sen S, Liu SM.

Neoplasma. 2012 Nov 25. doi: 10.4149/neo_2013_018. [Epub ahead of print]

PMID:
23176272
3.

Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection.

Qi P, Cheng SQ, Wang H, Li N, Chen YF, Gao CF.

PLoS One. 2011;6(12):e28486. doi: 10.1371/journal.pone.0028486. Epub 2011 Dec 8.

4.

Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers.

Zen K, Zhang CY.

Med Res Rev. 2012 Mar;32(2):326-48. doi: 10.1002/med.20215. Epub 2010 Nov 9. Review.

PMID:
22383180
5.

Circulating microRNAs as biomarkers for hepatocellular carcinoma.

Qu KZ, Zhang K, Li H, Afdhal NH, Albitar M.

J Clin Gastroenterol. 2011 Apr;45(4):355-60. doi: 10.1097/MCG.0b013e3181f18ac2.

PMID:
21278583
6.

MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma?

Giordano S, Columbano A.

Hepatology. 2013 Feb;57(2):840-7. doi: 10.1002/hep.26095. Epub 2012 Dec 26. Review.

PMID:
23081718
7.

Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis.

Xu J, Wu C, Che X, Wang L, Yu D, Zhang T, Huang L, Li H, Tan W, Wang C, Lin D.

Mol Carcinog. 2011 Feb;50(2):136-42. doi: 10.1002/mc.20712. Epub 2010 Dec 10.

PMID:
21229610
8.

Serum microRNA 143 and microRNA 215 as potential biomarkers for the diagnosis of chronic hepatitis and hepatocellular carcinoma.

Zhang ZQ, Meng H, Wang N, Liang LN, Liu LN, Lu SM, Luan Y.

Diagn Pathol. 2014 Jul 2;9:135. doi: 10.1186/1746-1596-9-135.

9.

Potential applications of miRNAs as diagnostic and prognostic markers in liver cancer.

Gailhouste L, Gomez-Santos L, Ochiya T.

Front Biosci (Landmark Ed). 2013 Jan 1;18:199-223. Review.

PMID:
23276918
10.

New kids on the block: diagnostic and prognostic microRNAs in hepatocellular carcinoma.

Ji J, Wang XW.

Cancer Biol Ther. 2009 Sep;8(18):1686-93. Review.

11.

Diagnosis of hepatocellular carcinoma: role of tumor markers and liver biopsy.

Gonzalez SA, Keeffe EB.

Clin Liver Dis. 2011 May;15(2):297-306, vii-x. doi: 10.1016/j.cld.2011.03.012. Review.

PMID:
21689614
12.

Circulating markers for prognosis of hepatocellular carcinoma.

Wong KF, Xu Z, Chen J, Lee NP, Luk JM.

Expert Opin Med Diagn. 2013 Jul;7(4):319-29. doi: 10.1517/17530059.2013.795146. Epub 2013 May 6. Review.

PMID:
23642136
13.

Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma.

Köberle V, Kronenberger B, Pleli T, Trojan J, Imelmann E, Peveling-Oberhag J, Welker MW, Elhendawy M, Zeuzem S, Piiper A, Waidmann O.

Eur J Cancer. 2013 Nov;49(16):3442-9. doi: 10.1016/j.ejca.2013.06.002. Epub 2013 Jun 26.

PMID:
23810247
14.

Circulating cell-free nucleic acids: promising biomarkers of hepatocellular carcinoma.

Zhou J, Shi YH, Fan J.

Semin Oncol. 2012 Aug;39(4):440-8. doi: 10.1053/j.seminoncol.2012.05.013. Review.

PMID:
22846861
15.

Hepatocellular carcinoma tumour markers: current role and expectations.

Rich N, Singal AG.

Best Pract Res Clin Gastroenterol. 2014 Oct;28(5):843-53. doi: 10.1016/j.bpg.2014.07.018. Epub 2014 Aug 22. Review.

PMID:
25260312
16.

Expression of serum exosomal microRNA-21 in human hepatocellular carcinoma.

Wang H, Hou L, Li A, Duan Y, Gao H, Song X.

Biomed Res Int. 2014;2014:864894. doi: 10.1155/2014/864894. Epub 2014 May 18.

17.

Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma.

Chen T, Xie G, Wang X, Fan J, Qiu Y, Zheng X, Qi X, Cao Y, Su M, Wang X, Xu LX, Yen Y, Liu P, Jia W.

Mol Cell Proteomics. 2011 Jul;10(7):M110.004945. doi: 10.1074/mcp.M110.004945. Epub 2011 Apr 25. Erratum in: Mol Cell Proteomics. 2011 Nov;10(11). doi:10.1074/mcp.A110.004945.

18.

Cancer-associated carbohydrate antigens as potential biomarkers for hepatocellular carcinoma.

Wu CS, Yen CJ, Chou RH, Li ST, Huang WC, Ren CT, Wu CY, Yu YL.

PLoS One. 2012;7(7):e39466. doi: 10.1371/journal.pone.0039466. Epub 2012 Jul 13.

19.

Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma.

Borel F, Konstantinova P, Jansen PL.

J Hepatol. 2012 Jun;56(6):1371-83. doi: 10.1016/j.jhep.2011.11.026. Epub 2012 Feb 5. Review.

20.

Diagnostic and prognostic value of alpha-fetoprotein, des-γ-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma.

Bertino G, Neri S, Bruno CM, Ardiri AM, Calvagno GS, Malaguarnera M, Toro A, Malaguarnera M, Clementi S, Bertino N, Di Carlo I.

Minerva Med. 2011 Oct;102(5):363-71. Review.

PMID:
22193346
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk